Heather Wenning, BS, CCRC

Signal Point Clinical Research CenterMiddletown, Ohio - 62801 |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS2
- SINCE2009

Study to Evaluate the Safety Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone Administered Intravenously to Patients With Colorectal Adenocarcinoma Previously Untreated for Metastatic Disease
May 2009 - December 2010
Adenocarcinoma
Neoplasm Metastasis
Colorectal Neoplasms
Ct-011
Folfox



